PathogenDx Expands Reach of Its Multiplexed Molecular Testing Technology
"Dynamic Dimensional Detection" Array technology is expanding into the clinical and agricultural spaces
Articles by PathogenDX
PathogenDx, Inc. Receives FDA Emergency Use Authorization for Industry’s First Microarray-Based COVID-19 Test
DetectX-Rv is ideally suited for small and medium clinical/CLIA labs to accurately detect COVID-19 easily, cost-effectively, and with high throughput
Multiplex Array Technology for Rapid COVID-19 Clade Variant Testing
A rapid, affordable adaptive surveillance test to screen for CoV-2 clade variants
PathogenDx Receives Federal Grant From the NIH as Part of the RADx Program
The capital will be used to scale up testing capacity of PathogenDx’s Microarray Assay for COVID-19 testing nationally
Microarray Technology Enhances COVID-19 Testing
PathogenDx combines RT-PCR and DNA microarray for greater specificity and multiplex capabilities
Advanced Microarray Testing Guides Public Health Decision Making
Improved testing platforms with greater specificity, throughput, and environmental testing capabilities are essential to support public health decisions